Pricing
  1. JP-listed companies
  2. MIZUHO MEDY CO.,LTD.
  3. Financials
  4. Revenue growth (%)

MIZUHO MEDY CO.,LTD. (4595)

Market cap
¥34.5B
P/E ratio
10.7x
Mizuho Medic develops and manufactures diagnostic test kits for hospitals and consumers, specializing in infectious disease testing including COVID-19 and influenza.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Dec 31, 2025-1.5-137.00%
Dec 31, 20244-110.67%
Dec 31, 2023-37.5-210.82%
Dec 31, 202233.8-84.07%
Dec 31, 2021212.4-714.38%
Dec 31, 2020-34.6-57716.67%
Dec 31, 20190.1-99.58%
Dec 31, 201814.2+6.36%
Dec 31, 201713.4-37.98%
Dec 31, 201621.5+801.26%
Dec 31, 20152.4-89.49%
Dec 31, 201422.8+1015.20%
Dec 31, 20132-81.30%
Dec 31, 201210.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat